Search results
Results From The WOW.Com Content Network
Quest Diagnostics Incorporated. Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. [3] Quest also maintains collaborative agreements with various hospitals and clinics across the globe. [4]
Preceded by. Robert A. Brown. Personal details. Alma mater. Bucknell University. Harvard Business School. Kenneth W. Freeman is an American former business executive and academic dean. He was previously the CEO of Quest Diagnostics and Masonite International. As of August 2023, he is the interim president of Boston University.
COVID-19 testing. Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection.
Celera Corporation. Celera is a subsidiary of Quest Diagnostics which focuses on genetic sequencing and related technologies. It was founded in 1998 as a business unit of Applera, spun off into an independent company in 2008, and finally acquired by Quest Diagnostics in 2011. [2]
Quest Diagnostics Training Center The Quest Diagnostics Training Center is the main headquarters and practice facility of the New York Giants . It was known as the Timex Performance Center, renamed in July 2013 when the Giants and Quest Diagnostics announced [9] a new partnership after the four-year partnership between the Giants and Timex ended.
In 1967, Brown founded MetPath, an American company providing clinical-laboratory services. MetPath was acquired by Corning Glass Works for $140 million in 1982 and later spun off as Quest Diagnostics (DGX) in 1996. He also founded HEARx in 1986, which was renamed to HearUSA and was acquired by Siemens AG for $130 million in 2011.
Here's the Quest Diagnostics Incorporated 2019 Form 10-K (latest one, filed February 2020) from the Securities and Exchange Commission's EDGAR database of corporate filings. It's a fairly comprehensive, candid description of the company and the industry, in 74 pages of small type plus several appendices.
Molecular diagnostics. Specialist using "QIAsymphony", an automation platform for molecular diagnostic tests. Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome, and how their cells express their genes as proteins, applying molecular biology to medical testing.